X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
male (28) 28
female (27) 27
oncology (27) 27
index medicus (25) 25
aged (24) 24
middle aged (23) 23
adult (19) 19
cancer (14) 14
chemotherapy (14) 14
lung neoplasms - drug therapy (14) 14
aged, 80 and over (11) 11
carcinoma, non-small-cell lung - drug therapy (10) 10
respiratory system (10) 10
treatment outcome (10) 10
gemcitabine (9) 9
lung cancer (9) 9
neoplasm staging (9) 9
prognosis (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
care and treatment (7) 7
deoxycytidine - administration & dosage (7) 7
deoxycytidine - analogs & derivatives (7) 7
disease-free survival (7) 7
hematology, oncology and palliative medicine (7) 7
lung cancer, non-small cell (7) 7
nsclc (7) 7
antineoplastic agents - therapeutic use (6) 6
cisplatin (6) 6
lung neoplasms - pathology (6) 6
medicine & public health (6) 6
pulmonary/respiratory (6) 6
survival (6) 6
animals (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
cell lung-cancer (5) 5
cisplatin - administration & dosage (5) 5
clinical-trials (5) 5
immunohistochemistry (5) 5
mutation (5) 5
pharmacology & pharmacy (5) 5
quality of life (5) 5
young adult (5) 5
adolescent (4) 4
biomarkers (4) 4
carcinoma (4) 4
docetaxel (4) 4
drug administration schedule (4) 4
egfr (4) 4
immunology (4) 4
kaplan-meier estimate (4) 4
lung neoplasms - mortality (4) 4
management (4) 4
metastasis (4) 4
molecular targeted therapy (4) 4
multivariate analysis (4) 4
patients (4) 4
prospective studies (4) 4
quality-of-life (4) 4
randomized-trial (4) 4
research (4) 4
retrospective studies (4) 4
thymus neoplasms - pathology (4) 4
adenocarcinoma - drug therapy (3) 3
analysis (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
antimetabolites, antineoplastic - adverse effects (3) 3
antimetabolites, antineoplastic - therapeutic use (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
article (3) 3
autoimmunity (3) 3
cancer research (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
european-organization (3) 3
gefitinib (3) 3
guanine - analogs & derivatives (3) 3
hemic and immune systems (3) 3
immunotherapy (3) 3
infusions, intravenous (3) 3
italy (3) 3
lung neoplasms - genetics (3) 3
mice (3) 3
mice, inbred c57bl (3) 3
neoplasm metastasis (3) 3
neoplasms, glandular and epithelial - drug therapy (3) 3
neoplasms, glandular and epithelial - pathology (3) 3
non-small-cell lung cancer (3) 3
pemetrexed (3) 3
phase-ii (3) 3
proportional hazards models (3) 3
prostate cancer (3) 3
protein kinase inhibitors - therapeutic use (3) 3
proteins (3) 3
surgery (3) 3
surveys and questionnaires (3) 3
survival analysis (3) 3
survival rate (3) 3
therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of molecular sciences, ISSN 1422-0067, 03/2019, Volume 20, Issue 6, p. 1373
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2013, Volume 13, Issue 1, pp. 22 - 22
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 11/2019, Volume 71, Issue 11, pp. 1964 - 1965
Journal Article
Anticancer Research, ISSN 0250-7005, 11/2018, Volume 38, Issue 11, p. 6029
Inhibiting androgen receptor (AR) signaling with androgen deprivation therapy (ADT) represents the mainstay of therapy for advanced and metastatic prostate... 
Therapy | Deprivation | Metastasis | Drug resistance | Resistance factors | Cancer therapies | Patients | Metastases | Androgens | Castration | Prostate cancer | Prostate | Cancer
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2018, Volume 36, Issue 34_suppl, pp. 59 - 59
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 8, pp. 910 - 915
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2007, Volume 8, Issue 6, pp. 500 - 512
Journal Article
Anticancer Research, ISSN 0250-7005, 07/2018, Volume 38, Issue 7, p. 3789
Journal Article
Journal Article
Journal Article
Current Urology Reports, ISSN 1527-2737, 11/2019, Volume 20, Issue 11, pp. 1 - 10
To critically review the potential clinical applications of prostate-specific membrane antigen (PSMA) radioactive ligands in renal cell carcinoma... 
Positron-emission tomography | Nephrology | Medicine & Public Health | Renal cell carcinoma | Prostate-specific membrane antigen | Neoangiogenesis | Diagnostic imaging | Response assessment | Urology | Antigens | Medical colleges | Carcinoma, Renal cell | PET imaging | Prostate cancer
Journal Article
Anticancer Research, ISSN 0250-7005, 07/2018, Volume 38, Issue 7, pp. 3789 - 3796
Immunotherapy with monoclonal antibodies against programmed cell death (PD-1), such as nivolumab and pembrolizumab, has significantly improved the survival of... 
Review | NSCLC | Programmed cell death (PD-1) | Programmed death ligand-1 (PD-L1) expression | Lung cancer | Immunotherapies | DEATH-LIGAND 1 | EGFR MUTATIONS | lung cancer | immunotherapies | CELL LUNG-CANCER | programmed cell death (PD-1) | PEMBROLIZUMAB | IMMUNE-CHECKPOINT | ONCOLOGY | IMMUNOTHERAPY | review | BLOCKADE | NIVOLUMAB | UP-REGULATION | ASSOCIATION
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e14075 - e14075
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 04/2012, Volume 7, Issue 4, pp. 672 - 680
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2012, Volume 69, Issue 2, pp. 309 - 315
Journal Article